Jupiter Topco LLC Invests $101.30 Million in Ventas, Inc. $VTR

Jupiter Topco LLC acquired a new stake in Ventas, Inc. (NYSE:VTR - Free Report) during the second quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 1,140,949 shares of the real estate investment trust's stock, valued at approximately $101,300,000. Jupiter Topco LLC owned about 0.22% of Ventas as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Dynamic Wealth Strategies LLC bought a new stake in Ventas during the first quarter valued at $25,000. Wiser Advisor Group LLC bought a new position in shares of Ventas in the 3rd quarter worth about $27,000. Silvant Capital Management LLC acquired a new position in shares of Ventas in the 2nd quarter valued at about $28,000. Meeder Asset Management Inc. bought a new stake in shares of Ventas during the 2nd quarter valued at about $30,000. Finally, IFC & Insurance Marketing Inc. bought a new stake in shares of Ventas during the 4th quarter valued at about $30,000. 94.18% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Ventas

In related news, Director Michael J. Embler acquired 2,500 shares of the firm's stock in a transaction on Wednesday, June 3rd. The stock was purchased at an average cost of $78.81 per share, with a total value of $197,025.00. Following the acquisition, the director owned 19,202 shares of the company's stock, valued at approximately $1,513,309.62. This trade represents a 14.97% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.53% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on VTR shares. The Goldman Sachs Group reiterated a "buy" rating and issued a $110.00 target price on shares of Ventas in a report on Tuesday, May 19th. Royal Bank Of Canada raised their price objective on shares of Ventas from $98.00 to $99.00 and gave the stock an "outperform" rating in a research report on Friday, August 14th. Weiss Ratings upgraded shares of Ventas from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Tuesday, July 21st. Scotiabank cut their target price on shares of Ventas from $95.00 to $88.00 and set a "sector perform" rating on the stock in a research note on Thursday, June 18th. Finally, Barclays assumed coverage on shares of Ventas in a report on Tuesday, July 7th. They issued an "equal weight" rating and a $99.00 price target for the company. Fourteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $98.00.

Ventas Stock Performance

Shares of VTR stock opened at $93.73 on Thursday. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.86. The firm has a fifty day simple moving average of $91.99 and a two-hundred day simple moving average of $87.47. Ventas, Inc. has a 12 month low of $66.38 and a 12 month high of $101.60. The firm has a market capitalization of $48.08 billion, a PE ratio of 173.57, a price-to-earnings-growth ratio of 2.16 and a beta of 0.69.

Ventas (NYSE:VTR - Get Free Report) last issued its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.96 by $0.01. The firm had revenue of $1.73 billion during the quarter, compared to analysts' expectations of $1.68 billion. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The business's revenue was up 21.7% on a year-over-year basis. During the same period last year, the company earned $0.87 earnings per share. Analysts forecast that Ventas, Inc. will post 3.89 EPS for the current fiscal year.

Ventas Profile

Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas' business model combines property ownership with active asset management and capital markets activity.

Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source